1. Home
  2. ENOV vs WLYB Comparison

ENOV vs WLYB Comparison

Compare ENOV & WLYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enovis Corporation

ENOV

Enovis Corporation

HOLD

Current Price

$27.07

Market Cap

1.7B

Sector

Industrials

ML Signal

HOLD

Logo John Wiley & Sons Inc.

WLYB

John Wiley & Sons Inc.

N/A

Current Price

$32.32

Market Cap

1.7B

ML Signal

N/A

Company Overview

Basic Information
Metric
ENOV
WLYB
Founded
1995
1807
Country
United States
United States
Employees
N/A
5200
Industry
Fluid Controls
Books
Sector
Industrials
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.7B
IPO Year
2008
N/A

Fundamental Metrics

Financial Performance
Metric
ENOV
WLYB
Price
$27.07
$32.32
Analyst Decision
Strong Buy
Analyst Count
6
0
Target Price
$51.17
N/A
AVG Volume (30 Days)
815.6K
952.0
Earning Date
11-06-2025
12-04-2025
Dividend Yield
N/A
4.38%
EPS Growth
N/A
N/A
EPS
N/A
1.87
Revenue
$2,233,266,000.00
$1,665,756,000.00
Revenue This Year
$9.27
$0.86
Revenue Next Year
$4.56
$2.66
P/E Ratio
N/A
$16.73
Revenue Growth
11.57
N/A
52 Week Low
$25.47
$32.32
52 Week High
$49.38
$46.81

Technical Indicators

Market Signals
Indicator
ENOV
WLYB
Relative Strength Index (RSI) 36.08 32.05
Support Level $26.69 $33.43
Resistance Level $30.93 $39.00
Average True Range (ATR) 1.33 0.70
MACD -0.12 -0.03
Stochastic Oscillator 7.31 0.00

Price Performance

Historical Comparison
ENOV
WLYB

About ENOV Enovis Corporation

Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.

About WLYB John Wiley & Sons Inc.

John Wiley & Sons Inc is a publisher and a trusted leader in research and learning. The company segment includes: Research, which includes the reporting lines of Research Publishing and Research Solutions, and Learning includes the Academic and Professional reporting lines and consists of publishing, courseware, and assessments. Its industry-principal content, services, platforms, and knowledge networks are tailored to meet the evolving needs of its customers and partners, including researchers, students, instructors, professionals, institutions, and corporations. The company empowers knowledge-seekers to transform today's obstacles into tomorrow's brightest opportunities. For more than two centuries, the company has been delivering on its timeless mission to unlock human potential.

Share on Social Networks: